Divestiture

A global coalition of advocates, doctors, and pharma giants launches Obesity Care Week, aiming to dismantle systemic barriers and fight pervasive weight bias.

Hain Celestial completes sale of Terra and Garden of Eatin' to pay down debt, betting its future on the high-margin tea, yogurt, and baby food markets.

An 8-month-old infant weighing just 5.5 kg receives a new liver from his father in a daring surgery, marking a milestone for pediatric care in India.

The airline will pay a massive fine for historical price-fixing, concluding a landmark legal battle that has reshaped the air cargo industry.

The FDA has greenlit Ascendis Pharma's once-weekly YUVIWEL for achondroplasia, a major step for patients that also carries significant business implications.

Over a year after a breach exposed 25 million Americans' health data, Conduent's delayed disclosure prompts legal action and questions corporate accountability.

As Cipla rolls out its affordable Liraglutide injection, the battle for the multi-billion dollar GLP-1 market intensifies, promising greater access for patients.

Treace Medical reports a Q4 revenue dip despite surgeon growth, revealing a strategic shift to lower-priced kits and a challenging 2026 outlook.

Endeavour Silver saw record 2025 revenue from new mines but posted a $119M loss due to financial instruments, high costs, and rising security risks in Mexico.

Grupo Elektra resolves its decades-long tax dispute with Mexico, but a massive provision leads to a historic net loss, overshadowing solid operational growth.

The infrastructure giant posted a 12.2% EBITDA jump fueled by North American highways and a record construction backlog, solidifying its US-focused strategy.

The diagnostics firm topped revenue forecasts with explosive growth in core tests, navigating a net loss with a strategic pivot into new markets.

After a $544M annual loss from impairment charges, the performance parts maker is cutting costs and exploring the sale of its Marucci baseball brand.

After a strategic pivot to focus purely on cell and gene therapy, BioLife reports strong revenue growth and a profitable quarter, eyeing further gains in 2026.

FTAI Infrastructure's aggressive acquisitions drove an 82% jump in adjusted earnings, but hefty debt and transaction costs led to a significant net loss.

Clipper Realty's Q4 results show a stark divide in NYC real estate, as soaring apartment rents struggle to offset deep losses from its troubled office portfolio.

The City of Beaconsfield's lawsuit against Montréal over millions in alleged overcharges has a trial date, setting the stage for a landmark legal battle.

A century-old Chicago food dynasty, Pastorelli Food Products, sees its iconic recipes and brand name hit the auction block in a $2.8M foreclosure sale.

After a banner 2025, TriMas is selling its aerospace unit to double down on packaging, armed with a major cash infusion and a new efficiency plan.

Calyxo's CVAC System shows a dramatic reduction in repeat procedures and costs, but recent safety warnings add complexity to its widespread adoption.